Endocyte, Inc. Announces Proposed Offering Of Common Stock

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WEST LAFAYETTE, Ind., March 25, 2014 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT) announced today that it is offering to sell 4.5 million shares of its common stock in an underwritten public offering. The company expects to grant the underwriters a 30-day option to purchase up to an additional 675,000 shares of common stock.

Help employers find you! Check out all the jobs and post your resume.

Back to news